Search Results for: cancer

Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

Press Release – Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.

Log In or Register as a healthcare professional to read the full article.

Read More »
meat cancer

New Study Reveals Link Between Meat Consumption and Cancer Risks

A comprehensive study finds that processed and red meats are linked to a higher risk of colorectal, stomach, and pancreatic cancers. Experts urge a drastic overhaul of dietary habits, recommending a reduction or elimination of processed meats and an increase in plant-based foods. Discover the latest findings and what they mean for global public health policies.

Read More »

Have a health question?

Share it with us and get it answered by a doctor!